$AME

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

Original reporting
Published Aug 26, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
9/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The acquisition is expected to be modestly accretive to 2026 adjusted earnings and adds $350 million of sales, enhancing AMETEK's growth trajectory.

02

Market read

The deal underscores continued consolidation in the industrial instrumentation market and may influence peer valuations.

03

What to watch

Potential antitrust review delays and the need to retain key Indicor talent.

Relevance 9/10Novelty 9/10Timing: today

Background

AMETEK announced the completion of its previously disclosed acquisition of Indicor Instrumentation, a portfolio of mission‑critical instrumentation businesses.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK completed a $5.0 billion cash acquisition of Indicor Instrumentation, adding $350 million of sales and being modestly accretive to 2026 earnings.

Expected impact

Short‑term upside as investors price in the accretive acquisition; medium‑term upside if integration synergies materialize.

Evidence & confidence

A $5 bn cash deal for a mid‑cap industrial group is material; the acquisition is accretive and adds recurring revenue streams.

Market effects

Strengthens the industrial instrumentation segment, pressuring peers to consider similar consolidation.

Boosts US industrial tech stocks; limited immediate effect on overseas competitors.

Adds to the narrative of large‑scale M&A in the industrial sector worldwide.

Counterpoint

The high cash outlay could strain AMETEK's balance sheet if integration costs exceed expectations.

Key entities

  • AMETEK, Inc.

    US‑listed industrial technology provider (NYSE: AME).

  • Indicor Instrumentation

    Portfolio of instrumentation businesses being acquired.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.